SPL 0.00% 9.7¢ starpharma holdings limited

Ann: Positive DEP Cabazitaxel Phase 2 Results in Multiple Cancer, page-68

  1. 2,253 Posts.
    lightbulb Created with Sketch. 325
    This statement sums up SPL perfectly!!!

    "It is the job of SPL's highly-paid senior management to convert the potential of trial results into actual commercial value. Unfortunately, no matter how much of shareholders' money that they pay to themselves, and no matter how many years that they get paid, successful commercial outcomes appear to be elusive. SPL needs to address its failure to become profitable and also its apparent lack of a realistic pathway to profitability. Years ago, these two strategic issues were less significant, but in my opinion they have gradually grown in importance to have now become by far the most important strategic issues facing SPL today."
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.7¢
Change
0.000(0.00%)
Mkt cap ! $40.00M
Open High Low Value Volume
9.7¢ 10.5¢ 9.6¢ $85.54K 874.2K

Buyers (Bids)

No. Vol. Price($)
7 172165 9.6¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 63883 3
View Market Depth
Last trade - 13.55pm 19/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.